Product
L-citrulline
6 clinical trials
11 indications
Indication
ALIIndication
Vaso-occlusive CrisisIndication
Ventricular Septal DefectIndication
Atrioventricular Septal DefectIndication
Atrial Septal DefectIndication
MalnutritionIndication
Hypertensive Disorders of PregnancyIndication
PreeclampsiaIndication
Gestational HypertensionIndication
AsthmaClinical trial
A Phase III Double-Blind, Randomized, Placebo Controlled, Multi-Center Clinical Study to Evaluate the Efficacy and Safety of Intravenous L-citrulline for the Prevention of Clinical Sequelae of Acute Lung Injury Induced by Cardiopulmonary Bypass in Pediatric Subjects Undergoing Surgery for Congenital Heart DefectsStatus: Completed, Estimated PCD: 2019-06-01
Clinical trial
A Phase I/IIA Open-label Dose-Finding Study With Subsequent Double-blind, Placebo-controlled, Randomized Study of L-citrulline in Sickle Cell Disease Presenting to Emergency Department (ED) in Vaso Occlusive Crisis (VOC) in Children, Adolescents and Young Adults (6 to 21 Years)Status: Recruiting, Estimated PCD: 2024-06-01
Clinical trial
A Phase III Double-Blind, Randomized, Placebo Controlled, Multi Center Clinical Study to Evaluate the Efficacy and Safety of Intravenous L-Citrulline for the Prevention of Clinical Sequelae of Acute Lung Injury Induced by Cardiopulmonary Bypass in Pediatric Patients Undergoing Surgery for Congenital Heart DefectsStatus: Recruiting, Estimated PCD: 2023-12-31
Clinical trial
Effects of Oral Citrulline Supplementation on Fat-free Mass in COPD Patients With MalnutritionStatus: Not yet recruiting, Estimated PCD: 2026-01-25
Clinical trial
Role of L-citrulline in Prevention of Pregnancy Associated Hypertension in Nulliparous WomenStatus: , Estimated PCD: 2024-07-30
Clinical trial
Study to Improve dEployment Related Asthma by Using L-citrulline Supplementation (SEALS)Status: Recruiting, Estimated PCD: 2028-10-01